Desonide foam: a review

  • Drugs Today (Barc). 2008 Jan;44(1):55-62. doi: 10.1358/dot.2008.44.1.1143847.
Daniel Parish  1 Noah Scheinfeld
Affiliations
  • 1. Pennsylvania Hospital, University of Pennsylvania, Philadelphia, PA, USA.
Abstract

Desonide foam is a newly approved topical corticosteroid preparation of 0.05% desonide. It has been shown effective compared with vehicle placebo in the treatment of mild-to-moderate atopic dermatitis in both pediatric and adult populations. Given the favorable safety profile of all Other desonide preparations and their utility as a low potency corticosteroid, desonide foam promises to be a useful addition to the armamentarium, when Other desonide vehicles might be less acceptable.

Products